home / stock / bgne / bgne short
Short Information | BeiGene Ltd. (NASDAQ:BGNE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 904,422 |
Total Actual Volume | 3,873,075 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 45,221 |
Average Short Percentage | 21.51% |
Is there a BGNE Short Squeeze or Breakout about to happen?
See the BGNE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $143.04 | $143.93 | $145.69 | $142.8 | 243,547 | 50,188 | 20.61% |
07-01-2024 | $144.3 | $144.89 | $148.94 | $143.4 | 153,790 | 23,736 | 15.43% |
06-28-2024 | $144.69 | $142.67 | $145 | $141.84 | 318,147 | 57,248 | 17.99% |
06-27-2024 | $142.27 | $145.58 | $148 | $141.31 | 276,015 | 75,960 | 27.52% |
06-26-2024 | $150.22 | $146.44 | $150.68 | $146 | 233,169 | 35,205 | 15.1% |
06-25-2024 | $155.95 | $150.99 | $155.95 | $150.93 | 332,871 | 42,715 | 12.83% |
06-24-2024 | $156.31 | $159.15 | $162.39 | $155.34 | 139,936 | 21,961 | 15.69% |
06-21-2024 | $153.45 | $156.11 | $158.57 | $150.88 | 217,941 | 38,378 | 17.61% |
06-20-2024 | $153.62 | $155.54 | $156 | $152 | 129,240 | 15,730 | 12.17% |
06-18-2024 | $158.39 | $154.7 | $159.47 | $152.71 | 170,761 | 22,011 | 12.89% |
06-17-2024 | $165.295 | $159.38 | $165.295 | $158.11 | 97,166 | 10,377 | 10.68% |
06-14-2024 | $163.87 | $162.58 | $163.99 | $160.64 | 174,057 | 41,643 | 23.92% |
06-13-2024 | $167 | $166.38 | $168.8 | $163.43 | 314,022 | 177,371 | 56.48% |
06-12-2024 | $157.75 | $168.11 | $169.17 | $156.5 | 401,710 | 138,861 | 34.57% |
06-11-2024 | $155.02 | $158.59 | $158.69 | $151.685 | 151,711 | 40,280 | 26.55% |
06-10-2024 | $155.14 | $156.07 | $157.845 | $154.58 | 78,315 | 16,323 | 20.84% |
06-07-2024 | $157.6 | $156.36 | $159.37 | $156.09 | 79,617 | 21,373 | 26.84% |
06-06-2024 | $157.81 | $157.6 | $159.91 | $156.5 | 84,336 | 20,876 | 24.75% |
06-05-2024 | $157.27 | $159.03 | $159.18 | $156.8 | 101,640 | 16,569 | 16.3% |
06-04-2024 | $148.99 | $155.09 | $155.38 | $148.03 | 175,084 | 37,617 | 21.49% |
News, Short Squeeze, Breakout and More Instantly...
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation Preliminary data suggest promising efficacy and tolerability Safety profile was consistent with results o...
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its presence and directly manage operations in the MENA region. T...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT. Live webcast of this event can be acce...